March 16, 2014
Biomedical Engineering Graduate Students Take Second Place in Orthopaedic Video Competition
On Sunday, March 16, Biomedical Engineering graduate students Youssef Farhat and Bryan Bobo heard the news: second place! The news comes months after they began promoting their video across the University of Rochester Medical Center. Farhat and Bobo stated that they submitted the video to emphasize the importance of collaboration between scientists and physicians in improving care in the field of orthopaedics. Their video, titled
Working Together for a Better Futurefeatures stories from physicians, scientists, and engineers in the Center for Musculoskeletal Research. The stories emphasize the high quality and collaborative nature of orthopaedic research at the University of Rochester. Farhat and Bobo
want to thank all of our colleagues who helped make filming the video possible, as well as the entire University of Rochester community for their tremendous support during the voting process....For their excellent work, Farhat and Bobo will share a second place trophy and $1,000 honorarium.
Last year, Farhat's video,
Who Cares About Orthopaedic Research?, took first place. Farhat, an MD-PhD trainee in the Medical Scientist Training Program, also points out that 2014 is the second year in a row that the University of Rochester took first place in the competition. Farhat comments,
I think that's a reflection of the excellence of this institution and its prominence, particularly in the field of orthopaedic research.
March 10, 2014
Andrew Cox Awarded Technology Development Grant for Influenza Vaccine
Andrew 'Andy' Cox, third-year graduate student in the Immunology-Microbiology-Virology graduate program and Medical Scientist Training Program, was awarded a technology development grant from the University of Rochester Office of Technology Transfer in January, with funds starting in April. Andy, as the PI, will investigate strategies to increase the usage of the live attenuated influenza vaccine in the lab of Steve Dewhurst, Ph.D., Chair of the Department of Microbiology & Immunology.
Andy hypothesizes one reason that this vaccine is currently underutilized is that it is not FDA approved in all children due to safety concerns in those under two and asthmatics. However, Andy has identified additional mutations in the influenza genome that increases its temperature sensitivity in tissue culture at physiologic temperatures. The impact of these mutations on the attenuation of these viruses will be examined in an animal model of influenza infection.